Pure Global
NCT06395896

The Effect of Breast Cancer Prevention Journey Program

The Effect of Breast Cancer Prevention Journey Program on Women's Health Beliefs Towards Breast Cancer: Quasi Experimental Study
Nurbanu Odacı·ClinicalTrials.gov·otherNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Breast Cancer Female
Drug/Device/Intervention
Breast Cancer Prevention Journey Program Group
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
Nurbanu Odacı
Funder
Lokman Hekim Üniversitesi
Location
Ankara, Turkey
Timeline & enrollment
Phase
N/A
Start date
May 20, 2024
End date
Jun 04, 2024
Enrollment
70 participants
Primary outcome

Champion's Health Belief Model Scale in Breast Cancer Screening

Summary

The aim of this quasi-experimental study is to determine the effect of the Breast Cancer
 Prevention Journey Program on health beliefs about breast cancer in women over 40 years of
 age who have never had a mammogram before. The research aims to answer the following basic
 questions:
 
 -Do women who participated in the Breast Cancer Prevention Journey Program have different
 health beliefs about breast cancer than women who did not participate in the program? The
 researchers will compare the program with routine care to see if the Breast Cancer
 Prevention Journey Program works. The study will be conducted in a quasi-experimental design
 with a pre-test post-test control group.
 
 Participants in the experimental group will first participate in the The fight against
 breast cancer training structured according to the Health Belief Model. One week after the
 training, the participants in the experimental group will be taken to mammography screening
 with free shuttles.
 
 Participants in the control group will not receive any additional intervention. This group
 will only receive routine intervention within the scope of the breast cancer screening
 program conducted by the Ministry of Health.

ICD-10 classifications
Malignant neoplasm: Breast, unspecifiedMalignant neoplasm of breastMalignant neoplasm of breastCarcinoma in situ of breast, unspecifiedPersonal history of malignant neoplasm of breast
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06395896
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06395896 through Pure Global AI's free database. This phase not specified trial is sponsored by Nurbanu Odacı and is currently Not yet recruiting. The study focuses on Breast Cancer Female. Target enrollment is 70 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.